Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study links brain function to alcohol addiction risk

NCT ID NCT04647422

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed study looked at how thinking skills (like flexibility and self-control) and social understanding (like reading emotions) are connected to alcohol use disorder. Researchers tested 216 people using puzzles, eye-tracking, and brain scans. The goal was to find early warning signs that could help predict who might develop alcohol problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help identify cognitive markers that predict alcohol use disorder risk, potentially guiding earlier interventions.
What could go wrong
This is an observational study, not a treatment trial. It cannot directly improve outcomes, and findings may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

216 people

The number who actually took part.

Started

Dec 2020

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1. AUD patients Inclusion criteria: * Patients between 18 and 60 years old, men or women, following AUD treatment * Having a diagnosis of alcohol use disorder according to DSM-5 criteria * Patients withdrawn of alcohol for at least 15 days * Patients being a native French speaker * Patients enrolled in the national healthcare insurance program * Patients consenting to participate to the study exclusion criteria: * A diagnosis of schizophrenia, of any other chronic psychotic state, or of bipolar disorder according to DSM-5 criteria * The presence of a current depressive episode as defined by DSM-5 criteria * The presence of another substance use disorder during the six months preceding the study, except for tobacco dependence. * The presence of any intellectual disability, of pervasive developmental disorders or learning difficulties (especially of dysphasia and dyspraxia) * The presence of any neurological disorder or any other disorder affecting the central nervous system including Korsakoff syndrome or Wernicke's encephalopathy * Having any uncorrected auditory or visual deficits 2. First-degree relatives of AUD patients Inclusion criteria: * Participants between 18 and 60 years old, men or women * Current and past absence of any alcohol use disorder or any other substance use disorder as defined by DSM-5 diagnostic criteria * Participants having at least one first-degree relative presenting an alcohol use disorder (father or sibling) * Participants being a native French speaker * Participants enrolled in the national healthcare insurance program * Participants consenting to participate to the study exclusion criteria: * The presence of any alcohol use disorder or any other substance use disorder as defined by DSM-5 diagnostic criteria, except for tobacco dependence * A diagnosis of schizophrenia, of any other chronic psychotic state, or of bipolar disorder according to DSM-5 criteria * The presence of a current depressive episode as defined by DSM-5 criteria * The presence of any alcohol use disorder in the participant's biological mother in order to exclude fetal alcohol spectrum disorders due to prenatal alcohol intoxication * The presence of any intellectual disability, of pervasive developmental disorders or learning difficulties (especially of dysphasia and dyspraxia) * The presence of any neurological disorder or any other disorder affecting the central nervous system * Participants having any uncorrected auditory or visual deficits 3. Healthy control participants (the inclusion and non-inclusion criteria of investigation groups 2 and 4 are identical): Inclusion criteria: * Participants between 18 and 60 years old, men or women * Current and past absence of any alcohol use disorder or any other substance use disorder as defined by DSM-5 diagnostic criteria * Participants being a native French speaker * Participants enrolled in the national healthcare insurance program * Participants consenting to participate to the study exclusion criteria: * The presence of any alcohol use disorder or any other substance use disorder as defined by DSM-5 diagnostic criteria, except for tobacco dependence * A diagnosis of schizophrenia, of any other chronic psychotic state, or of bipolar disorder according to DSM-5 criteria * The presence of a current depressive episode as defined by DSM-5 criteria * Having any first-degree relative with alcohol use disorder (parents, siblings, children) according to DSM-5 diagnostic criteria * The presence of any intellectual disability, of pervasive developmental disorders or learning difficulties (especially of dysphasia and dyspraxia) * The presence of any neurological disorder or any other disorder affecting the central nervous system * Participants having any uncorrected auditory or visual deficits

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Damien JOLLY

    Reims, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.